Go to content

Awards & Recognition

ICES brings together the best and brightest scientific talent. Many of our scientists are internationally recognized in their fields and receive national and international awards and recognition for their important work.

Filters

Gillian Hawker Award

2019: Awarded to Dr. Jonathan Zipursky by the Institute of Health Policy, Management and Evaluation

Canada Research Chair in Drug Policy Research and Evaluation

2019: Canada Research Chair in Drug Policy Research and Evaluation awarded to Dr. Tara Gomes by CIHR.

Frederick Banting and Charles Best Canada Graduate Scholarship (CGS-D) CIHR Doctoral Award

2019: Awarded to Dr. Jonathan Zipursky for "Perinatal maternal opioid use: exploring prescribing trends, and the maternal and neonatal safety of postpartum opioids using administrative data"

Crohns and Colitis Canada Rising Star Award

2018: Awarded to Dr. Sanjay Murthy. Recipients of the award are innovative and productive leaders who are advancing Crohn's and colitis research in Canada.

CIHR Fellowship

2018: Awarded to Dr. Alanna Weisman for the project "Association Between Allopurinol and Cardiovascular Events, Mortality and End-Stage Renal Disease in Diabetes"

Diabetes Canada Postdoctoral Fellowship

2018: Awarded to Dr. Alanna Weisman for the project "Associations between elevated uric acid, allopurinol, and end-stage renal disease in diabetes: Population-based cohort studies"

CIHR Canada Research Chair

2018: Awarded to Dr. Murray Krahn in health technology assessment.

CIHR New Investigator Grant in Maternal, Reproductive, Child and Youth Health

2018: Awarded to Dr. Rayzel Shulman in partnership with the Institute of Nutrition, Metabolism and Diabetes for "Bridging the gap to prevent adverse events between pediatric and adult diabetes care."

The Bill Silverman Prize

2017: Awarded to Drs. Laura Rosella and David Henry for the paper “Risk of bias in systematic reviews of non-randomized studies of adverse cardiovascular effects of thiazolidinediones and cyclooxygenase-2 inhibitors: application of a new Cochrane risk of bias tool” by Cochrane at its annual summit. The prize is offered annually and explicitly acknowledges Cochrane's value of criticism, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about healthcare by providing the best possible evidence on the effects of healthcare interventions.